KDIGO guidelines recommend dietary phosphate restriction to lower serum phosphate
levels in CKD stages 3–5. Recent studies suggest that dietary phosphate intake is only …

Background Serum phosphate is a known risk factor for cardiovascular events and mortality
in people with chronic kidney disease (CKD), however data on the association of these …

Elevated serum phosphate levels have been linked with vascular calcification and mortality
among dialysis patients. The relationship between phosphate and mortality has not been …

Background: Abnormalities of mineral metabolism are prevalent in patients with kidney
failure and are associated with increased risk for cardiovascular events. There are limited …

Increased serum phosphate levels are associated with chronic kidney disease (CKD),
cardiovascular events, and mortality. 1-3 Practice guidelines recommend dietary …

Hyperphosphatemia has been associated with increased mortality in chronic kidney disease
but the nature of such a relation in the general population is unclear. To investigate the …

Background. Hyperphosphataemia is associated with increased mortality in patients with
chronic kidney disease (CKD) stage IV or on dialysis. Furthermore, in animal studies …

The importance of phosphate homeostasis in chronic kidney disease (CKD) has been
recognized for decades, but novel insights—which are frequently relevant to everyday …

Background. Dietary phosphorus intake is usually restricted in dialysis patients but the
associations of dietary phosphorus intake with mortality in moderate chronic kidney disease …

Results At baseline, prescribed daily phosphate was restricted to levels≤ 870, 871 to 999,
1000, 1001 to 2000 mg, and not restricted in 300, 314, 307, 297, and 533 participants …